Cargando…

SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling

The osteoanabolic agent abaloparatide (ABL) has been shown to significantly increase total hip BMD over an 18-month period in postmenopausal women with osteoporosis. However, it remains unknown if these gains predominantly occur in the cortical or trabecular compartments of the proximal femur, and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Winzenrieth, Renaud, Ominsky, Michael S, Wang, Yamei, Humbert, Ludovic, Weiss, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209294/
http://dx.doi.org/10.1210/jendso/bvaa046.255

Ejemplares similares